These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 17078187

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intermittent claudication: a plea for guidelines for medical management.
    Powell JT.
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):451-2. PubMed ID: 17196850
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of hypertension in peripheral arterial disease: does the choice of drugs matter?
    Singer DR, Kite A.
    Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):701-8. PubMed ID: 18375152
    [Abstract] [Full Text] [Related]

  • 7. How many claudicants should be prescribed statins?
    Harrison EM, Holdsworth RJ.
    Eur J Vasc Endovasc Surg; 2003 Apr; 25(4):367-8. PubMed ID: 12651177
    [No Abstract] [Full Text] [Related]

  • 8. Painful legs, aching heart: Reducing cardiovascular risk in patients with peripheral arterial disease with angiotensin-converting enzyme inhibition.
    Gupta MK, Verma S.
    Can J Cardiol; 2005 Feb; 21(2):194-5. PubMed ID: 15729422
    [No Abstract] [Full Text] [Related]

  • 9. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O, Welten GM, Bax JJ, Poldermans D.
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract] [Full Text] [Related]

  • 10. Buflomedil in peripheral arterial disease: trials and tribulations.
    Conte MS.
    Circulation; 2008 Feb 12; 117(6):717-9. PubMed ID: 18268159
    [No Abstract] [Full Text] [Related]

  • 11. [Beta-adrenergic blockade and peripheral arterial insufficiency].
    Sørlie D.
    Tidsskr Nor Laegeforen; 1995 Feb 28; 115(6):696-7. PubMed ID: 7900127
    [No Abstract] [Full Text] [Related]

  • 12. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Limbs International Medicinal Buflomedil (LIMB) Study Group, Leizorovicz A, Becker F.
    Circulation; 2008 Feb 12; 117(6):816-22. PubMed ID: 18212283
    [Abstract] [Full Text] [Related]

  • 13. [Thrombosis and antithrombotic agents in peripheral artery disease].
    Emmerich J.
    Arch Mal Coeur Vaiss; 2002 Nov 12; 95 Spec No 7():59-62. PubMed ID: 12500607
    [Abstract] [Full Text] [Related]

  • 14. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
    Paraskevas KI.
    J Vasc Surg; 2008 Sep 12; 48(3):776-7; author reply 777. PubMed ID: 18727983
    [No Abstract] [Full Text] [Related]

  • 15. Endothelial dysfunction and the promise of ACE inhibitors.
    Rockett JL.
    Am J Nurs; 1999 Oct 12; 99(10):44-9; quiz 50. PubMed ID: 10542849
    [No Abstract] [Full Text] [Related]

  • 16. The importance of managing cardiovascular risk in the treatment of hypertension: the role of ACE inhibitors and ARBs.
    Pierson CA, Epstein BJ, Roberts ME.
    J Am Acad Nurse Pract; 2008 Nov 12; 20(11):529-38. PubMed ID: 19128336
    [No Abstract] [Full Text] [Related]

  • 17. Letter by De Backer et al regarding article, "Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study".
    De Backer TL, Vander Stichele RH, Van Bortel LM.
    Circulation; 2008 Sep 02; 118(10):e151. PubMed ID: 18765384
    [No Abstract] [Full Text] [Related]

  • 18. Hypertension in peripheral arterial disease.
    Clement DL, De Buyzere ML, Duprez DA.
    Curr Pharm Des; 2004 Sep 02; 10(29):3615-20. PubMed ID: 15579058
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular risk in patients with peripheral vascular diseases.
    Stoica A, Ginghină C.
    Rom J Intern Med; 2008 Sep 02; 46(4):275-83. PubMed ID: 19480293
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin receptor blockers: novel role in high-risk patients.
    Javed U, Deedwania PC.
    Cardiol Clin; 2008 Nov 02; 26(4):507-26. PubMed ID: 18929228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.